The dopamine hypothesis of schizophrenia is a structure, accrediting indications of schizophrenia to a distressed and agitated dopaminergic indicator transduction. The growth of enriched antipsychotic medicines was directed by a hunt for dopamine blockers founded on the notion that schizophrenia is, partly, a hyperdopaminergic state. So from the choices given above, it can be concluded that, drugs that block the effects of dopamine in the brain reduce or eliminate symptoms of schizophrenia.